Chitosan for mucosal vaccination
- 2 October 2001
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 52 (2), 139-144
- https://doi.org/10.1016/s0169-409x(01)00197-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal deliveryVaccine, 2000
- Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine AntigensInfection and Immunity, 2000
- Mucosal immunity and tolerance: relevance to vaccine developmentImmunological Reviews, 1999
- Preparation of alginate gel beads containing chitosan salt and their functionInternational Journal of Pharmaceutics, 1999
- Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticlesVaccine, 1997
- Adjuvants for human vaccines—current status, problems and future prospectsVaccine, 1995
- The role of nasopharyngeal lymphoid tissueImmunology Today, 1992
- The mucosal immune system: from fundamental concepts to vaccine developmentVaccine, 1992
- Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral doseInternational Journal of Pharmaceutics, 1992
- Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patchesJournal of Controlled Release, 1990